Tissue Repair & Cytoprotective Research Peptides
Thymosin beta-4 fragment (17–23)
Also known as TB-500 (ambiguous name) · LKKTETQ
Cell/lab studies onlyNot approved for human use in the US
Last reviewed: 2026-11-19
Overview
Regulatory status
No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextEvidence at a glance
Key sources
Targeted factual corrections checked against the sources below on November 19, 2026. This is not an exhaustive systematic review; discovery dates, exact molecular forms and current labels require separate verification.
Related compounds
- BPC-157
Same scientific class · A 15-amino-acid chain. · Early human trials
- Thymosin beta-4
Same scientific class · A 43-amino-acid chain. · Late-stage human trials